Literature DB >> 17964839

Beta-ureidopropionase deficiency presenting with congenital anomalies of the urogenital and colorectal systems.

J Yaplito-Lee1, J Pitt, J Meijer, L Zoetekouw, R Meinsma, A B P van Kuilenburg.   

Abstract

Beta-ureidopropionase deficiency (McKusick 606673) is an autosomal recessive condition caused by mutations in the UPB1 gene. To date, five patients have been reported, including one putative case detected through newborn screening. Clinical presentation includes neurological and developmental problems. Here, we report another case of beta-ureidopropionase deficiency who presented with congenital anomalies of the urogenital and colorectal systems and with normal neurodevelopmental milestones. Analysis of a urine sample, because of the suspicion of renal stones on ultrasound, showed strongly elevated levels of the characteristic metabolites, N-carbamyl-beta-amino acids. Subsequent analysis of UPB1 identified a novel mutation 209 G>C (R70P) in exon 2 and a previously reported splice receptor mutation IVS1-2A>G. Expression studies of the R70P mutant enzyme showed that the mutant enzyme did not possess any residual activity. Long-term follow-up is required to determine the clinical significance of the beta-ureidopropionase deficiency in our patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964839     DOI: 10.1016/j.ymgme.2007.09.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  8 in total

1.  A Korean Case of β-Ureidopropionase Deficiency Presenting with Intractable Seizure, Global Developmental Delay, and Microcephaly.

Authors:  Jun Hwa Lee; André B P van Kuilenburg; N G G M Abeling; Valeria Vasta; Si Houn Hahn
Journal:  JIMD Rep       Date:  2015-02-01

2.  Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions.

Authors:  Lillian M Zwemer; Sarah L Nolin; Patricia M Okamoto; Marcia Eisenberg; Heather C Wick; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2016-10-25       Impact factor: 3.050

3.  Systems pharmacology assessment of the 5-fluorouracil pathway.

Authors:  Filipe A Muhale; Barbara A Wetmore; Russell S Thomas; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2011-03       Impact factor: 2.533

Review 4.  Inborn errors of purine and pyrimidine metabolism.

Authors:  A Jurecka
Journal:  J Inherit Metab Dis       Date:  2009-03-15       Impact factor: 4.982

Review 5.  Lower urinary tract development and disease.

Authors:  Hila Milo Rasouly; Weining Lu
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-02-13

6.  Autozygome sequencing expands the horizon of human knockout research and provides novel insights into human phenotypic variation.

Authors:  Ahmed B Alsalem; Anason S Halees; Shamsa Anazi; Shomoukh Alshamekh; Fowzan S Alkuraya
Journal:  PLoS Genet       Date:  2013-12-19       Impact factor: 5.917

7.  Clinical, biochemical and molecular analysis of 13 Japanese patients with β-ureidopropionase deficiency demonstrates high prevalence of the c.977G > A (p.R326Q) mutation [corrected].

Authors:  Yoko Nakajima; Judith Meijer; Doreen Dobritzsch; Tetsuya Ito; Rutger Meinsma; Nico G G M Abeling; Jeroen Roelofsen; Lida Zoetekouw; Yoriko Watanabe; Kyoko Tashiro; Tomoko Lee; Yasuhiro Takeshima; Hiroshi Mitsubuchi; Akira Yoneyama; Kazuhide Ohta; Kaoru Eto; Kayoko Saito; Tomiko Kuhara; André B P van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  2014-02-14       Impact factor: 4.982

8.  Clinical and genetic analysis of 7 Chinese patients with β-ureidopropionase deficiency.

Authors:  Yulian Fang; Chunquan Cai; Chao Wang; Bei Sun; Xinjie Zhang; Wenxuan Fan; Wenchao Hu; Yingtao Meng; Shuxiang Lin; Chunhua Zhang; Yuqin Zhang; Jianbo Shu
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.